Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs - Wikidata - wikimedia - TriplyDB

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

http://www.wikidata.org/entity/Q28082603

about

Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts.Current Clinical Brain Tumor Imaging Neurobehavioral radiation mitigation to standard brain cancer therapy regimens by Mn(III) n-butoxyethylpyridylporphyrin-based redox modifier.Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma.Functional network analysis of gene-phenotype connectivity associated with temozolomide.Characterization of the distribution, retention, and efficacy of internal radiation of 188Re-lipid nanocapsules in an immunocompromised human glioblastoma model.

P2860

Q33627880-D9BD9D9C-C652-443D-94DF-0DFD386C4558 Q36367172-8E9A42E6-C54E-4B75-807E-EBBC1457D6DE Q38768495-445B43EA-E615-4C6C-B5DA-7D77439453BB Q38839352-E312620B-ADCC-4914-A7C8-D1D6E1031E96 Q47258480-EAE97578-8F34-4399-A7E2-E5472C4DE6A9 Q48458408-F14E2DCE-FAF3-487A-B452-D896442A2408

P2860

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

http://www.wikidata.org/entity/Q28082603

description

2015 nî lūn-bûn

@nan

2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

@ast

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

@en

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

@nl

type

label

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

@ast

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

@en

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

@nl

prefLabel

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

@ast

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

@en

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

@nl

P1433

Q28082603-740561C6-AEC1-40DC-975A-B40B020E88AD

P1476

Q28082603-95F90B5E-6928-46A1-9346-DE59C1413304

P2093

Q28082603-25023782-8BB1-442D-8989-94B3737A17E5

Q28082603-38203E91-955A-44F9-A57E-067C9AF77834

Q28082603-693AAC02-700D-4C33-9F34-84A745235FFB

P2860

Q28082603-01C67E87-4A7C-42D0-8F80-ECBFAC9452C4

Q28082603-0728CD3A-FA9B-4CF7-80D9-00735411A316

Q28082603-07F7DC93-BF9A-4AC0-86FF-292F6B76BAB5

Q28082603-08A8831F-FCAE-46CC-81E8-87AF8D3124C3

Q28082603-0A1CB870-34AF-41DB-BDAA-76D003D0A426

Q28082603-12A6B57B-1772-48F6-A624-4ED979E12B7B

Q28082603-133755C2-B702-4871-8C5D-0FBA77AF6F63

Q28082603-14A16AAE-CE90-43FA-A3A5-74786806085D

Q28082603-155A5C01-EB75-434C-ACC7-FAD8287F6FC6

Q28082603-1BBEE8A2-542D-4E21-A733-9D9202DC0F90

P304

Q28082603-C86E8F96-0397-417D-A586-7CA88894AB8C

P31

Q28082603-A4C2E9FF-A556-4134-9B44-DB2064231B11

P356

Q28082603-67A4C89A-9FBA-46A0-BAC7-B52DD92F9DCD

P407

Q28082603-4649CD0B-5B19-4EC9-A054-9EA487310E00

P433

Q28082603-0BB193FC-6931-4862-96CA-390AFFC86564

P478

Q28082603-A7BECD39-0AD9-438C-A2B5-BA26B10E8A6F

P50

Q28082603-9D0E3805-CCF6-4BDF-BC18-E415CFA0811C

Q28082603-EA081224-FE37-4707-8BBC-540F8809F3A7

P577

Q28082603-6C639BC9-AE1D-471A-AD3A-3B9A96AF86E5

P698

Q28082603-B0BCBD97-8AFF-4BEF-A37D-1A54A25C3827

P932

Q28082603-AB8920E5-5DE8-4F1C-A04D-7BAB5F4E4F67

P356

P1433

British Journal of Radiology

P1476

Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs

@en

P2093

A Seidlitz

http://www.w3.org/2001/XMLSchema#string

B Beuthien-Baumann

http://www.w3.org/2001/XMLSchema#string

H H Kitzler

http://www.w3.org/2001/XMLSchema#string

P2860

IDH1 and IDH2 mutations in gliomas

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

The 2007 WHO classification of tumours of the central nervous system

The potential origin of glioblastoma initiating cells

Emerging methods for disease monitoring in malignant gliomas

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

A randomized trial of bevacizumab for newly diagnosed glioblastoma

P304

20150354

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1259/BJR.20150354

http://www.w3.org/2001/XMLSchema#string

P407

P433

1053

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Mechthild Krause

Claere von Neubeck

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26159214

http://www.w3.org/2001/XMLSchema#string

P932

4743581

http://www.w3.org/2001/XMLSchema#string